MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 192 filers reported holding MYRIAD GENETICS INC in Q3 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $711,743 | -29.3% | 44,373 | +2.2% | 0.01% | -16.7% |
Q2 2023 | $1,006,476 | -0.4% | 43,420 | -0.2% | 0.01% | -14.3% |
Q1 2023 | $1,010,737 | +60.8% | 43,510 | +0.4% | 0.01% | +75.0% |
Q4 2022 | $628,704 | -24.5% | 43,329 | -0.7% | 0.00% | -33.3% |
Q3 2022 | $833,000 | +6.2% | 43,643 | +1.1% | 0.01% | +20.0% |
Q2 2022 | $784,000 | -31.6% | 43,148 | -5.2% | 0.01% | -16.7% |
Q1 2022 | $1,146,000 | -14.0% | 45,492 | -5.8% | 0.01% | -14.3% |
Q4 2021 | $1,333,000 | -15.3% | 48,282 | -0.9% | 0.01% | -12.5% |
Q3 2021 | $1,573,000 | +3.4% | 48,711 | -2.1% | 0.01% | +60.0% |
Q2 2021 | $1,522,000 | +4.7% | 49,755 | +4.2% | 0.01% | 0.0% |
Q1 2021 | $1,454,000 | +52.3% | 47,741 | -1.2% | 0.01% | +25.0% |
Q4 2020 | $955,000 | +48.1% | 48,315 | -2.3% | 0.00% | +33.3% |
Q3 2020 | $645,000 | +12.2% | 49,467 | -2.4% | 0.00% | 0.0% |
Q2 2020 | $575,000 | -18.3% | 50,673 | +2.9% | 0.00% | -25.0% |
Q1 2020 | $704,000 | -50.0% | 49,231 | -4.7% | 0.00% | -20.0% |
Q4 2019 | $1,407,000 | -6.3% | 51,664 | -1.4% | 0.01% | -16.7% |
Q3 2019 | $1,501,000 | +2.0% | 52,418 | -1.0% | 0.01% | 0.0% |
Q2 2019 | $1,471,000 | -15.6% | 52,959 | +0.9% | 0.01% | -14.3% |
Q1 2019 | $1,743,000 | +9.0% | 52,486 | -4.6% | 0.01% | 0.0% |
Q4 2018 | $1,599,000 | -34.1% | 54,995 | +4.3% | 0.01% | -12.5% |
Q3 2018 | $2,426,000 | +27.1% | 52,744 | +3.3% | 0.01% | +14.3% |
Q2 2018 | $1,908,000 | +54.7% | 51,060 | +22.3% | 0.01% | +75.0% |
Q1 2018 | $1,233,000 | -31.5% | 41,741 | -20.3% | 0.00% | -33.3% |
Q4 2017 | $1,799,000 | -3.2% | 52,394 | +2.0% | 0.01% | -14.3% |
Q3 2017 | $1,859,000 | +48.0% | 51,379 | +5.7% | 0.01% | +75.0% |
Q2 2017 | $1,256,000 | +57.4% | 48,602 | +16.9% | 0.00% | +33.3% |
Q1 2017 | $798,000 | +23.3% | 41,571 | +7.1% | 0.00% | +50.0% |
Q4 2016 | $647,000 | -99.9% | 38,824 | -0.3% | 0.00% | -33.3% |
Q3 2016 | $801,077,000 | -32.6% | 38,925 | +0.2% | 0.00% | -40.0% |
Q2 2016 | $1,189,300,000 | -21.1% | 38,866 | -3.4% | 0.01% | -16.7% |
Q1 2016 | $1,507,000,000 | -15.1% | 40,248 | -2.0% | 0.01% | -14.3% |
Q4 2015 | $1,774,000,000 | +116075.5% | 41,087 | +0.8% | 0.01% | 0.0% |
Q3 2015 | $1,527,000 | -99.9% | 40,747 | -0.1% | 0.01% | +16.7% |
Q2 2015 | $1,386,758,000 | +2002.7% | 40,799 | +2090.0% | 0.01% | – |
Q1 2015 | $65,950,000 | +3.3% | 1,863 | -0.6% | 0.00% | – |
Q4 2014 | $63,862,000 | -61.2% | 1,875 | -56.0% | 0.00% | -100.0% |
Q3 2014 | $164,463,000 | +22.1% | 4,264 | +23.2% | 0.00% | 0.0% |
Q2 2014 | $134,702,000 | -4.5% | 3,461 | -16.1% | 0.00% | 0.0% |
Q1 2014 | $141,000,000 | +422.2% | 4,124 | +220.4% | 0.00% | – |
Q4 2013 | $27,001,000 | -54.5% | 1,287 | -49.0% | 0.00% | – |
Q3 2013 | $59,314,000 | +48.6% | 2,524 | +69.9% | 0.00% | – |
Q2 2013 | $39,928,000 | – | 1,486 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |